Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong · Delayed Price · Currency is HKD 5.36
-0.07 (-1.20%)
Nov 11, 2026, 4:08 PM HKT
HKG:0719 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 8,053 | 8,755 | 8,466 | 8,101 | 7,503 | 6,560 |
Revenue Growth | -5.20% | 3.41% | 4.51% | 7.97% | 14.37% | 9.23% |
Gross Profit Gross Profit Growth | 1,429 | 1,592 | 1,985 | 2,321 | 1,988 | 1,736 |
Operating Income Operating Income Growth | 284.24 | 357.73 | 510.63 | 512.15 | 465.87 | 403.67 |
Net Income Net Income Growth | 228.71 | 289.89 | 470.02 | 496.51 | 411.06 | 348.55 |
Earnings Per Share EPS Growth | 0.33 | 0.42 | 0.68 | 0.72 | 0.61 | 0.56 |
EPS Growth | -39.96% | -38.23% | -5.56% | 18.03% | 9.75% | 6.89% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Pharmaceutical Intermediates and other Products Pharmaceutical Intermediates and other Products Growth | 3,135 | 2,550 | 2,262 | 2,113 | 2,116 |
Offset Offset Growth | -1,893 | -2,049 | -1,863 | -1,789 | -1,627 |
Chemical Raw Materials Chemical Raw Materials Growth | 2,659 | 2,751 | 3,147 | 3,191 | 2,758 |
Preparations Preparations Growth | 4,854 | 5,215 | 4,555 | 3,988 | 3,313 |
Total Total Growth | 8,755 | 8,466 | 8,101 | 7,503 | 6,560 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,195 | 1,397 | 1,245 | 918.33 | 1,159 | 744.66 |
Total Debt Total Debt Growth | 1,226 | 1,482 | 1,666 | 1,359 | 1,384 | 1,646 |
Net Cash (Debt) Net Cash Growth | -31.12 | -85.2 | -421.45 | -440.36 | -225.11 | -901.58 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.04 | -0.12 | -0.61 | -0.64 | -0.34 | -1.44 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 393.27 | 533.73 | 367.61 | 265.28 | 758.24 | 259.12 |
Capital Expenditures CapEx Growth | -82.84 | -115.6 | -212.42 | -325.13 | -244.76 | -249.23 |
Free Cash Flow Free Cash Flow Growth | 310.43 | 418.13 | 155.19 | -59.85 | 513.48 | 9.89 |
Free Cash Flow Growth | 15.42% | 169.43% | - | - | 5092.02% | -92.94% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 17.74% | 18.19% | 23.45% | 28.66% | 26.50% | 26.46% |
Operating Margin | 3.53% | 4.09% | 6.03% | 6.32% | 6.21% | 6.15% |
Pretax Margin | 3.30% | 4.10% | 6.30% | 6.58% | 6.29% | 6.42% |
Profit Margin | 2.84% | 3.31% | 5.55% | 6.13% | 5.48% | 5.31% |
FCF Margin | 3.85% | 4.78% | 1.83% | -0.74% | 6.84% | 0.15% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.175 | 0.150 | 0.275 | 0.250 | 0.200 | 0.150 |
Dividend Per Share Growth | -36.85% | -45.45% | 10.00% | 25.00% | 33.33% | 0% |
Dividend Yield | 3.27% | 1.18% | 2.15% | 1.56% | 0.85% | 1.69% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.87 | 30.29 | 18.56 | 21.75 | 38.17 | 16.00 |
Forward PE | 13.33 | 19.70 | 19.70 | 19.70 | 19.70 | 19.70 |
P/FCF Ratio | 23.17 | 21.00 | 56.20 | - | 30.56 | 563.90 |
PS Ratio | 0.89 | 1.00 | 1.03 | 1.33 | 2.09 | 0.85 |